An expanded-access clinical study of thiotepa (DSP-1958) high-dose chemotherapy before autologous hematopoietic stem cell transplantation in patients with malignant lymphoma

Thiotepa, an antineoplastic ethylenimine alkylating agent that can penetrate the central nervous system, was recently approved in Japan as high-dose chemotherapy prior to autologous hematopoietic stem cell transplantation (HSCT) for patients with malignant lymphoma. To further evaluate the safety an...

Descripción completa

Detalles Bibliográficos
Autores principales: Nishikori, Momoko, Masaki, Yasufumi, Fujii, Nobuharu, Ikeda, Takashi, Takahara-Matsubara, Mariko, Sugimoto, Saori, Kondo, Eisei
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Singapore 2021
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8619653/
https://www.ncbi.nlm.nih.gov/pubmed/34826108
http://dx.doi.org/10.1007/s12185-021-03263-y

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8619653/
https://www.ncbi.nlm.nih.gov/pubmed/34826108
http://dx.doi.org/10.1007/s12185-021-03263-y

Ejemplares similares